{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=34660&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=34620&ordering=-accession","results":[{"accession":"CLO:0008368","name":"PAb 101 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0008367","name":"PAb 100 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0008366","name":"PA96 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0008365","name":"PA95P cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0008364","name":"PA94 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0008363","name":"PA90P cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0008362","name":"PA317 LXSN 6E7 cell","definition":"['disease: amphotropic retroviral packaging line']","term_type":"cell line"},{"accession":"CLO:0008361","name":"PA317 LXSN 6E6 cell","definition":"['disease: amphotropic retroviral packaging line']","term_type":"cell line"},{"accession":"CLO:0008360","name":"PA317 LXSN 16E7 cell","definition":"['disease: amphotropic retroviral packaging line']","term_type":"cell line"},{"accession":"CLO:0008359","name":"PA317 LXSN 16E6E7 cell","definition":"['disease: amphotropic retroviral packaging line']","term_type":"cell line"},{"accession":"CLO:0008358","name":"PA317 LXSN 16E6 cell","definition":"['disease: amphotropic retroviral packaging line']","term_type":"cell line"},{"accession":"CLO:0008357","name":"PA317 LXSN cell","definition":"['disease: produces amphotropic control   retrovirus; G418 resistant']","term_type":"cell line"},{"accession":"CLO:0008356","name":"PA317 cyclin E-S cell","definition":"['disease: produces a retrovirus containing the   human cyclin E-S gene']","term_type":"cell line"},{"accession":"CLO:0008355","name":"PA317 cyclin E-L cell","definition":"['disease: produces a retrovirus containing the   human cyclin E-L gene']","term_type":"cell line"},{"accession":"CLO:0008354","name":"PA317 cell line   containing JR-gal cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0008353","name":"PA317 cell","definition":"['disease: amphotropic retroviral packaging line']","term_type":"cell line"},{"accession":"CLO:0008352","name":"PA2.1 cell","definition":"['disease: hybridoma']","term_type":"cell line"},{"accession":"CLO:0008351","name":"PA1-CEF cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0008350","name":"PA-1 cell","definition":"['disease: teratocarcinoma (ovary   primary)']","term_type":"cell line"},{"accession":"CLO:0008349","name":"Pa Kel-2 cell","definition":"['disease: Ehlers-Danlos syndrome, type I (autosomal   dominant type)']","term_type":"cell line"}]}